ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Quetiapine Fumarate Sustained Release Tablets Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-24G17630
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Quetiapine Fumarate Sustained Release Tablets Market Research Report 2024
BUY CHAPTERS

Global Quetiapine Fumarate Sustained Release Tablets Market Research Report 2024

Code: QYRE-Auto-24G17630
Report
August 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Teva Pharmaceutical Industries
Dr. Reddy’s Laboratories
Sun Pharmaceutical Industries
Mylan N.V.
Torrent Pharmaceuticals
Lupin Ltd
Sandoz Inc
Luye Pharma Limited
PHARMATHEN INVESTMENTS GROUP LIMITED
Seroquel

Quetiapine Fumarate Sustained Release Tablets Market

The global Quetiapine Fumarate Sustained Release Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Quetiapine Fumarate Sustained Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Quetiapine Fumarate Sustained Release Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Quetiapine Fumarate Sustained Release Tablets in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Quetiapine Fumarate Sustained Release Tablets include Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Mylan N.V., Torrent Pharmaceuticals, Lupin Limited, Sandoz, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate Sustained Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate Sustained Release Tablets.
The Quetiapine Fumarate Sustained Release Tablets market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quetiapine Fumarate Sustained Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quetiapine Fumarate Sustained Release Tablets companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Quetiapine Fumarate Sustained Release Tablets Market Report

Report Metric Details
Report Name Quetiapine Fumarate Sustained Release Tablets Market
Segment by Type
  • 50mg
  • 200mg
  • 300mg
  • 400mg
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Mylan N.V., Torrent Pharmaceuticals, Lupin Limited, Sandoz
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Quetiapine Fumarate Sustained Release Tablets company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Quetiapine Fumarate Sustained Release Tablets Market report?

Ans: The main players in the Quetiapine Fumarate Sustained Release Tablets Market are Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Mylan N.V., Torrent Pharmaceuticals, Lupin Limited, Sandoz

What are the Application segmentation covered in the Quetiapine Fumarate Sustained Release Tablets Market report?

Ans: The Applications covered in the Quetiapine Fumarate Sustained Release Tablets Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Quetiapine Fumarate Sustained Release Tablets Market report?

Ans: The Types covered in the Quetiapine Fumarate Sustained Release Tablets Market report are 50mg, 200mg, 300mg, 400mg

Recommended Reports

Sustained Release Tablets

Antipsychotic Drugs

Pharmaceutical Ingredients

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 50mg
1.2.3 200mg
1.2.4 300mg
1.2.5 400mg
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Sustained Release Tablets Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Perspective (2019-2030)
2.2 Global Quetiapine Fumarate Sustained Release Tablets Growth Trends by Region
2.2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Region (2019-2024)
2.2.3 Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Region (2025-2030)
2.3 Quetiapine Fumarate Sustained Release Tablets Market Dynamics
2.3.1 Quetiapine Fumarate Sustained Release Tablets Industry Trends
2.3.2 Quetiapine Fumarate Sustained Release Tablets Market Drivers
2.3.3 Quetiapine Fumarate Sustained Release Tablets Market Challenges
2.3.4 Quetiapine Fumarate Sustained Release Tablets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Quetiapine Fumarate Sustained Release Tablets Players by Revenue
3.1.1 Global Top Quetiapine Fumarate Sustained Release Tablets Players by Revenue (2019-2024)
3.1.2 Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Players (2019-2024)
3.2 Global Quetiapine Fumarate Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Quetiapine Fumarate Sustained Release Tablets Revenue
3.4 Global Quetiapine Fumarate Sustained Release Tablets Market Concentration Ratio
3.4.1 Global Quetiapine Fumarate Sustained Release Tablets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Quetiapine Fumarate Sustained Release Tablets Revenue in 2023
3.5 Global Key Players of Quetiapine Fumarate Sustained Release Tablets Head office and Area Served
3.6 Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Product and Application
3.7 Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Quetiapine Fumarate Sustained Release Tablets Breakdown Data by Type
4.1 Global Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Type (2019-2024)
4.2 Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Type (2025-2030)
5 Quetiapine Fumarate Sustained Release Tablets Breakdown Data by Application
5.1 Global Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Application (2019-2024)
5.2 Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Quetiapine Fumarate Sustained Release Tablets Market Size (2019-2030)
6.2 North America Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2019-2024)
6.4 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Quetiapine Fumarate Sustained Release Tablets Market Size (2019-2030)
7.2 Europe Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2019-2024)
7.4 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size (2019-2030)
8.2 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2019-2024)
8.4 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size (2019-2030)
9.2 Latin America Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2019-2024)
9.4 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size (2019-2030)
10.2 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2019-2024)
10.4 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Luye Pharma Limited
11.1.1 Luye Pharma Limited Company Details
11.1.2 Luye Pharma Limited Business Overview
11.1.3 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Introduction
11.1.4 Luye Pharma Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
11.1.5 Luye Pharma Limited Recent Development
11.2 PHARMATHEN INVESTMENTS GROUP LIMITED
11.2.1 PHARMATHEN INVESTMENTS GROUP LIMITED Company Details
11.2.2 PHARMATHEN INVESTMENTS GROUP LIMITED Business Overview
11.2.3 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Introduction
11.2.4 PHARMATHEN INVESTMENTS GROUP LIMITED Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
11.2.5 PHARMATHEN INVESTMENTS GROUP LIMITED Recent Development
11.3 Seroquel
11.3.1 Seroquel Company Details
11.3.2 Seroquel Business Overview
11.3.3 Seroquel Quetiapine Fumarate Sustained Release Tablets Introduction
11.3.4 Seroquel Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
11.3.5 Seroquel Recent Development
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Details
11.4.2 Teva Pharmaceutical Industries Business Overview
11.4.3 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Introduction
11.4.4 Teva Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
11.4.5 Teva Pharmaceutical Industries Recent Development
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Company Details
11.5.2 Dr. Reddy's Laboratories Business Overview
11.5.3 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Introduction
11.5.4 Dr. Reddy's Laboratories Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
11.5.5 Dr. Reddy's Laboratories Recent Development
11.6 Sun Pharmaceutical Industries
11.6.1 Sun Pharmaceutical Industries Company Details
11.6.2 Sun Pharmaceutical Industries Business Overview
11.6.3 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Introduction
11.6.4 Sun Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
11.6.5 Sun Pharmaceutical Industries Recent Development
11.7 Mylan N.V.
11.7.1 Mylan N.V. Company Details
11.7.2 Mylan N.V. Business Overview
11.7.3 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Introduction
11.7.4 Mylan N.V. Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
11.7.5 Mylan N.V. Recent Development
11.8 Torrent Pharmaceuticals
11.8.1 Torrent Pharmaceuticals Company Details
11.8.2 Torrent Pharmaceuticals Business Overview
11.8.3 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Introduction
11.8.4 Torrent Pharmaceuticals Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
11.8.5 Torrent Pharmaceuticals Recent Development
11.9 Lupin Limited
11.9.1 Lupin Limited Company Details
11.9.2 Lupin Limited Business Overview
11.9.3 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Introduction
11.9.4 Lupin Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
11.9.5 Lupin Limited Recent Development
11.10 Sandoz
11.10.1 Sandoz Company Details
11.10.2 Sandoz Business Overview
11.10.3 Sandoz Quetiapine Fumarate Sustained Release Tablets Introduction
11.10.4 Sandoz Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
11.10.5 Sandoz Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
Teva Pharmaceutical Industries
Dr. Reddy’s Laboratories
Sun Pharmaceutical Industries
Mylan N.V.
Torrent Pharmaceuticals
Lupin Ltd
Sandoz Inc
Luye Pharma Limited
PHARMATHEN INVESTMENTS GROUP LIMITED
Seroquel
List of Tables
 Table 1. Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of 50mg
 Table 3. Key Players of 200mg
 Table 4. Key Players of 300mg
 Table 5. Key Players of 400mg
 Table 6. Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2019-2024)
 Table 10. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2025-2030)
 Table 12. Quetiapine Fumarate Sustained Release Tablets Market Trends
 Table 13. Quetiapine Fumarate Sustained Release Tablets Market Drivers
 Table 14. Quetiapine Fumarate Sustained Release Tablets Market Challenges
 Table 15. Quetiapine Fumarate Sustained Release Tablets Market Restraints
 Table 16. Global Quetiapine Fumarate Sustained Release Tablets Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Players (2019-2024)
 Table 18. Global Top Quetiapine Fumarate Sustained Release Tablets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quetiapine Fumarate Sustained Release Tablets as of 2023)
 Table 19. Ranking of Global Top Quetiapine Fumarate Sustained Release Tablets Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Quetiapine Fumarate Sustained Release Tablets Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Headquarters and Area Served
 Table 22. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Product and Application
 Table 23. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Type (2019-2024)
 Table 27. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Type (2025-2030)
 Table 29. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Application (2019-2024)
 Table 31. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Application (2025-2030)
 Table 33. North America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Luye Pharma Limited Company Details
 Table 49. Luye Pharma Limited Business Overview
 Table 50. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product
 Table 51. Luye Pharma Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024) & (US$ Million)
 Table 52. Luye Pharma Limited Recent Development
 Table 53. PHARMATHEN INVESTMENTS GROUP LIMITED Company Details
 Table 54. PHARMATHEN INVESTMENTS GROUP LIMITED Business Overview
 Table 55. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product
 Table 56. PHARMATHEN INVESTMENTS GROUP LIMITED Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024) & (US$ Million)
 Table 57. PHARMATHEN INVESTMENTS GROUP LIMITED Recent Development
 Table 58. Seroquel Company Details
 Table 59. Seroquel Business Overview
 Table 60. Seroquel Quetiapine Fumarate Sustained Release Tablets Product
 Table 61. Seroquel Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024) & (US$ Million)
 Table 62. Seroquel Recent Development
 Table 63. Teva Pharmaceutical Industries Company Details
 Table 64. Teva Pharmaceutical Industries Business Overview
 Table 65. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product
 Table 66. Teva Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024) & (US$ Million)
 Table 67. Teva Pharmaceutical Industries Recent Development
 Table 68. Dr. Reddy's Laboratories Company Details
 Table 69. Dr. Reddy's Laboratories Business Overview
 Table 70. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product
 Table 71. Dr. Reddy's Laboratories Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024) & (US$ Million)
 Table 72. Dr. Reddy's Laboratories Recent Development
 Table 73. Sun Pharmaceutical Industries Company Details
 Table 74. Sun Pharmaceutical Industries Business Overview
 Table 75. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product
 Table 76. Sun Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024) & (US$ Million)
 Table 77. Sun Pharmaceutical Industries Recent Development
 Table 78. Mylan N.V. Company Details
 Table 79. Mylan N.V. Business Overview
 Table 80. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product
 Table 81. Mylan N.V. Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024) & (US$ Million)
 Table 82. Mylan N.V. Recent Development
 Table 83. Torrent Pharmaceuticals Company Details
 Table 84. Torrent Pharmaceuticals Business Overview
 Table 85. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product
 Table 86. Torrent Pharmaceuticals Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024) & (US$ Million)
 Table 87. Torrent Pharmaceuticals Recent Development
 Table 88. Lupin Limited Company Details
 Table 89. Lupin Limited Business Overview
 Table 90. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product
 Table 91. Lupin Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024) & (US$ Million)
 Table 92. Lupin Limited Recent Development
 Table 93. Sandoz Company Details
 Table 94. Sandoz Business Overview
 Table 95. Sandoz Quetiapine Fumarate Sustained Release Tablets Product
 Table 96. Sandoz Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024) & (US$ Million)
 Table 97. Sandoz Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Quetiapine Fumarate Sustained Release Tablets Picture
 Figure 2. Global Quetiapine Fumarate Sustained Release Tablets Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Type: 2023 VS 2030
 Figure 4. 50mg Features
 Figure 5. 200mg Features
 Figure 6. 300mg Features
 Figure 7. 400mg Features
 Figure 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Application: 2023 VS 2030
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Others Case Studies
 Figure 13. Quetiapine Fumarate Sustained Release Tablets Report Years Considered
 Figure 14. Global Quetiapine Fumarate Sustained Release Tablets Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Quetiapine Fumarate Sustained Release Tablets Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region: 2023 VS 2030
 Figure 17. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Players in 2023
 Figure 18. Global Top Quetiapine Fumarate Sustained Release Tablets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quetiapine Fumarate Sustained Release Tablets as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Quetiapine Fumarate Sustained Release Tablets Revenue in 2023
 Figure 20. North America Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2019-2030)
 Figure 22. United States Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2019-2030)
 Figure 26. Germany Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2019-2030)
 Figure 34. China Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2019-2030)
 Figure 42. Mexico Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2019-2030)
 Figure 46. Turkey Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Luye Pharma Limited Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
 Figure 50. PHARMATHEN INVESTMENTS GROUP LIMITED Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
 Figure 51. Seroquel Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
 Figure 52. Teva Pharmaceutical Industries Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
 Figure 53. Dr. Reddy's Laboratories Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
 Figure 54. Sun Pharmaceutical Industries Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
 Figure 55. Mylan N.V. Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
 Figure 56. Torrent Pharmaceuticals Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
 Figure 57. Lupin Limited Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
 Figure 58. Sandoz Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2019-2024)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Quetiapine Fumarate API Market Research Report 2024
Global Quetiapine Market Research Report 2025
Global Quetiapine Fumarate Tablets Market Research Report 2024
Global Quetiapine Fumarate Market Insights Forecast to 2030
Bedaquiline Fumarate Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Theophylline Sustained Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Paliperidone Extended Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tenofovir Alafenamide Fumarate Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Sustained and Controlled Release Formulations Market Research Report 2025
Global Sustained and Controlled Release Formulations Market Research Report 2025
Cefaclor Sustained Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Risperidone Oral Tablets Market Research Report 2024
Global Capecitabine Fumarate Market Research Report 2025
Global Doxazosin Mesylate Extended Release Tablets Market Research Report 2024
Fluorouracil Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lafutidine Tablets Market Research Report 2024
Global Lacidipine Tablets Market Research Report 2024
Diclofenac Sodium Sustained release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Formoterol Fumarate API Market Research Report 2025
Global Tenofovir Alafenamide Fumarate Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions